Pharmacy software providers FDS and Amplicare announced a strategic merger that executives said was aimed to support the acceleration of pharmacies as essential healthcare providers.
With the merger, FDS said its clients will have access to Amplicare's platform, which includes Medicare plan comparison and eligibility tools. Amplicare clients now will be able to take advantage of FDS's New Era Pharmacy platform with software solutions that enable clinical care, improve financial health, and offer valuable data insights into pharmacy operations.
The merger is effective immediately. FDS CEO Adam McMullin will continue to serve as CEO of the combined organization, now serving over 15,500 pharmacies nationwide. The company will remain based in Fort Worth, Texas with additional locations in New York City and Columbia, Md.
"With FDS and Amplicare joining together, our two companies are more than just the sum of our parts," said McMullin said. "Our customers have long asked for the types of solutions Amplicare provides, and now we can offer those to them while also providing Amplicare customers with our world-class financial, clinical, and business intelligence solutions. With their help, our New Era Pharmacy platform can improve the health of more pharmacies and patients than ever before. Pharmacies are doing more for their communities than ever before. They've set a new standard, and we want to do everything we can to support them."
The companies said that the merger of FDS and Amplicare would expand the availability of its Medicare and Medicaid plan comparison tools.
"Amplicare has a proven record of enabling pharmacies and their patients to make data-driven decisions," said Amplicare CEO J. Bennet Waters. "We are eager to integrate Amplicare's capabilities into FDS' existing solutions, and we are very confident in the power of these combined organizations. Among other observations, COVID-19 has made it clear that pharmacies have critical roles to play in the continuing digital transformation of healthcare, and we are excited to expand the tools we provide to pharmacists and the patients they serve."